SCHEMBL30358637

SCHEMBL30358637

CC(C)(C)OC(=O)NCCC(F)(F)S(=O)(=O)c1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 5/20 0.42
▸ CA1 P00915 5/20 0.42
▸ CA2 P00918 5/20 0.42
▸ CA9 Q16790 5/20 0.42
▸ ABCC9 O60706 1/20 0.42
▸ ABCC8 Q09428 1/20 0.42
▸ KCNJ11 Q14654 1/20 0.42
▸ KCNJ8 Q15842 1/20 0.42
▸ MALT1 Q9UDY8 1/20 0.41
▸ BCHE P06276 1/20 0.40
▸ PDK2 Q15119 1/20 0.40
▸ CKS1B P61024 1/20 0.39
▸ SKP1 P63208 1/20 0.39
▸ SKP2 Q13309 1/20 0.39
▸ IDO1 P14902 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ DRD2 P14416 2/20 0.39
▸ POLB P06746 1/20 0.38
▸ NQO2 P16083 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30565852 0.84 ABCC9 (0.43) ABCC9ABCC8KCNJ11KCNJ8KDM4E
SCHEMBL30358640 0.82 LMNA (0.48) CA12CA1CA2CA9L3MBTL1
SCHEMBL25468014 0.82 CA1 (0.46) CA12CA1CA2CA9MALT1
SCHEMBL15124929 0.80 ALOX5AP (0.49) CA12CA1CA2CA9MALT1
SCHEMBL8617523 0.79 CA1 (0.48) CA12CA1CA2CA9MALT1
SCHEMBL30358626 0.78 PDK2 (0.41) ABCC9ABCC8KCNJ11KCNJ8PDK2
SCHEMBL24214288 0.75 BCHE (0.43) CA12CA1CA2MALT1BCHE
SCHEMBL30358635 0.74 ABCC9 (0.40) CA2ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL30358645 0.74 PKM (0.41) ABCC9ABCC8KCNJ11KCNJ8KDM4E
SCHEMBL30565849 0.74 ABCC9 (0.42) ABCC9ABCC8KCNJ11KCNJ8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116710467-A Photooxidation reduction protein modification 罗莎琳德·富兰克林研究所 2023-09-05 — — CN disclosed
US-20230272002-A1 PHOTOREDOX PROTEIN MODIFICATION THE ROSALIND FRANKLIN INSTITUTE (GB) 2023-08-31 — — US disclosed
EP-4182327-A1 PHOTOREDOX PROTEIN MODIFICATION The Rosalind Franklin Institute (GB) 2023-05-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230272002-A1 PHOTOREDOX PROTEIN MODIFICATION PPOX, CACYBP, BRI3BP CA12 639/4885CA1 1284/4885CA2 598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback